The FDA has warned consumers that the sexual enhancement supplement Weekend Warrior contains an undisclosed ingredient and should not be purchased or used.
The FDA has concluded that compared to the use of imipenem and cilastatin for injection, Doribax carries an increased risk of death and lower clinical cure rates.
A report by a pharmacist claiming to have found one capsule of Tikosyn (dofetilide) in a bottle of Effexor XR (venlafaxine HCl extended-release) capsules has prompted Pfizer to initiate a recall of three of its products.
Baxter announced a voluntary recall of a single lot of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 6000mL (Ambu-Flex II).
Ben Venue Laboratories announced a nationwide recall of Roxane's Acetylcysteine Solution 10%.
Mylan announced that its subsidiary Agila Specialties is conducting a nationwide recall of 10 lots of Etomidate Injection 2mg/mL.
Medisca has recalled additional lots of L-citrulline after testing showed it did not contain any L-citrulline.
MyNicKnaxs, LLC., is recalling all lots of nine weight loss supplements after all were found to contain phenolphthalein and/or sibutramine.
The FDA is warning consumers to not purchase or use Arth-Q, a product sold as a dietary supplement for joint, muscle, and arthritic pain after it was found to contain ibuprofen.
The FDA has requested clinical trial data on Onglyza and Kombiglyze XR due to the possibility of an increase in heart failure.